Brigham and Women's Hospital

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).

937 total trials 145 currently recruiting 608 completed early-phase tilt top decile by trial count

Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.

Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.

Top-decile sponsor footprint

Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 64/100

608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

937 total, page 14 of 19

COMPLETED NA

Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia

NCT02419547

COMPLETED NA

Flexibility and Strength Training in Asthma

NCT02370004

TERMINATED Phase 2

Tranexamic Acid and Thromboelastography During Cesarean Delivery

NCT02026297

TERMINATED NA

Influence of Lumbar Ultrasound on Resident Learning Curve for Lateral Labor Epidural Placement

NCT02826668

COMPLETED Phase 3

Combined Medication for Improved Analgesia in Superficial Pain

NCT02194088

TERMINATED

APOL1 Gene Variants in African American Kidney Transplant Recipients

NCT01442402

COMPLETED NA

Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism

NCT02171273

COMPLETED Phase 1

Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants

NCT01853111

COMPLETED NA

High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)

NCT02064738

COMPLETED NA

Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection

NCT02084706

COMPLETED NA

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

NCT02015806

COMPLETED NA

Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients

NCT02879357

TERMINATED NA

Salt and TH-17 in Healthy Human Subjects

NCT02261688

COMPLETED NA

The Study of Physical Activity Rewards After Knee Surgery

NCT01970631

COMPLETED NA

Personalized Risk Estimator for Rheumatoid Arthritis Family Study

NCT02046005

COMPLETED Phase 4

Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes

NCT02008591

COMPLETED

Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program

NCT03326206

COMPLETED NA

Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.

NCT01928797

COMPLETED

Study of the Physical Activity in Anesthesiologists

NCT01989494

COMPLETED NA

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

NCT02192606

TERMINATED NA

Synchronization to Improve Non-Adherence to Cardiovascular Medications

NCT01963156

TERMINATED Phase 2

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

NCT01895127

COMPLETED

Multi-scale Modeling of Sleep Behaviors in Social Networks

NCT02846077

COMPLETED NA

Evaluation of Yoga for Substance Use Risk Factors in a School Setting

NCT01821950

COMPLETED NA

The Health Log: A Randomized Clinical Trial

NCT01913080

COMPLETED Phase 4

Hypoglycemia and Autonomic Nervous System Function-B

NCT03429946

COMPLETED NA

Multi-center Clinical Trial of Limiting Resident Work Hours on ICU Patient Safety

NCT02134847

TERMINATED Phase 4

Metformin, Muscle Energetics, and Vascular Function in Older Adults With Peripheral Artery Disease

NCT01901224

COMPLETED Phase 2

A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

NCT01748695

COMPLETED NA

Walnut Consumption, Endothelial Function, and Biomarkers

NCT01884363

COMPLETED NA

Relative Patient Benefits of a Hospital-PCMH Collaboration Within an ACO to Improve Care Transitions

NCT02130570

COMPLETED Phase 1

Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

NCT01855360

COMPLETED

Preoperative Cognitive Screening of Elderly Surgical Patients

NCT01826825

COMPLETED NA

Effects of Light on Melatonin and Contractions in Pregnant Women

NCT01863446

COMPLETED Phase 2

Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions

NCT01847209

COMPLETED Phase 3

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

NCT01754259

COMPLETED Phase 3

Cardiovascular Inflammation Reduction Trial

NCT01594333

COMPLETED Phase 4

Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography

NCT01683825

COMPLETED

Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, Mexico

NCT02549495

COMPLETED Phase 2

Role of the Isomerase Pin-1 in the Development and Treatment of Asthma

NCT01691612

COMPLETED NA

The Effects of Trazodone on Sleep Apnea Severity

NCT01817907

COMPLETED NA

Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and Technology

NCT02258594

COMPLETED Phase 2

Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis

NCT01689441

COMPLETED NA

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

NCT01468675

COMPLETED NA

Endoscopic Suturing for Primary Obesity Treatment

NCT01662024

COMPLETED Phase 3

Borage and Echium Seed Oils for Asthma

NCT01560988

COMPLETED

Evaluation of Catheter Placement for Renal Replacement Therapy in Patients With Acute Kidney Injury

NCT02200120

COMPLETED

Beliefs and Practice Intentions of Future Ob/Gyn Residents Regarding Reproductive Healthcare

NCT01763073

TERMINATED Phase 2

Riluzole Augmentation Pilot in Depression (RAPID) Trial

NCT01703039

TERMINATED Phase 1

Functional Applications of Hyperpolarized 129Xe MRI

NCT01697332

← Previous Page 14 of 19 Next →

Phase Distribution

PhaseTrial count
Phase 1 90
Phase 2 107
Phase 3 47
Phase 4 77

What is open in the Brigham and Women's Hospital pipeline

145 recruiting of 937 indexed (15% open); 608 completed (65%).

Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).

Top condition: Type 2 Diabetes (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Brigham and Women's Hospital: open-pipeline peers nationwide

Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share Brigham and Women's HospitalColumbia UniversityHoffmann-La RocheUniversity of MinnesotaUniversity of California, Los AngelesIncyte CorporationNorthwestern UniversityNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 937 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Brigham and Women's Hospital page

937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.

  • 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.